Actinic Keratosis Market By Treatments (Destructive Treatment, Photodynamic Therapy, Topical Medications, Chemical Peels And Dermabrasion) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Actinic keratosis (AK) or solar keratosis are keratotic papules, macules, and plaques arising from the intraepidermal proliferation of keratinocytes due to exposure to ultraviolet radiation. Although AKs and squamous cell carcinoma progression are rare, AKs still pose a concern because most cutaneous squamous cell carcinomas result from pre-existing AKs. Due to this, clinicians recommend routine treatment of AKs. This report studies the current and prospects of the global actinic keratosis treatment market.

For this report, the global actinic keratosis market is studied in terms of treatment type and geographical distribution. Based on treatment type, this market is segmented into destructive treatment (liquid nitrogen cryotherapy, surgical therapy), photodynamic therapy (5-aminolevulinic acid, methyl aminolevulinate), topical medications (5-fluorouracil, imiquimod, ingenolmebutate, diclofenac sodium), and chemical peels and dermabrasion. The market size and forecast for each considered segment are provided for 2014–2022, along with their respective CAGRs (value %) for the forecast durationof22016–2022t.

Geographically, the global actinic keratosis market is studied for the following regional and country-level markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Each country-level market (and Middle East, Africa, and Latin America markets) thus covered in the report includes the cumulative market size and forecast of destructive treatment, photodynamic therapy, topical medications, chemical peels, and others. In addition, since photodynamic therapy has opened further avenues for effective AK treatment, this section also presents the exclusive market size and forecast for the 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL) segments for the country-level and Middle East, Africa, and Latin America markets. The market size and forecast, along with growth rates, are provided for the periods 2014–2022 and 2016–2022, respectively.

Along with quantitative presentations, this report also includes an analysis of market environment factors such as drivers, restraints, and opportunities that determine the overall trends in the actinic keratosis market. Competition assessment tools such as attractive investment propositions, market competitive analysis by key players, and market inclination insights are also incorporated in this study. This report concludes with a profile of major companies active in the development, manufacturing, and sale of AK treatments. Such profiling is done based on the business description, financial health, product portfolio, and news coverage of such players.

Based on treatment types, the global actinic keratosis market is categorized into:

Destructive Treatment

  • Liquid Nitrogen Cryotherapy
  • Surgical Therapy

Photodynamic Therapy

  • 5-aminolevulinic acid (ALA)
  • Methyl aminolevulinate (MAL)

Topical Medications

  • 5-fluorouracil (5-FU)
  • Imiquimod
  • Ingenolmebutate
  • Diclofenac Sodium
  • Chemical Peel and Others

In 2015, destructive treatments accounted for the largest share of the overall actinic keratosis market. Based on their proven efficiency and cost-effectiveness, cryotherapy and surgical methods are considered the gold standard for AK treatment worldwide. Cryosurgery is the largest segment across all the available treatment methods and takes over 50% of the destructive treatment market. Laser treatments such as carbon dioxide and erbium:yttrium:aluminum: garnet are also increasingly preferred by clinicians due to their effectiveness and aesthetic appeal. Topical medications constitute a prolonged treatment regimen and play a key role in AK treatment; however, patient compliance is a key issue that holds back the growth of this segment. Yet, cheaper treatment costs favor the stability of these topical medications, particularly in the middle- and low-income markets. Photodynamic therapy is the fastest-growing segment through the forecast period due to the growing demand for non-invasive treatments and the aesthetic appeal of photodynamic therapy.

North America is the largest market for actinic keratosis treatments due to the growing prevalence of AK and high public awareness about the prevention and management of skin cancer. In 2015, the U.S. held the largest share in the global actinic keratosis market, owing to the high prevalence of AK in the country, supplemented by favorable reimbursements for AK treatment. Asia-Pacific is the fastest-progressing regional market for AK treatments. Australia has the highest prevalence of actinic keratosis, with a range between 40% and 50% in adults.

Growing awareness in a potential population group, improving healthcare infrastructure, and healthcare expenditure are this market's key drivers. Japan is also actively expanding the market for actinic keratosis treatment in terms of revenue. Japan as a market is probably 2-3 years behind Europe in developing actinic keratosis.

Frequently Asked Question:

The market for Actinic Keratosis Market is expected to reach USD$ XX Mn in 2022.

TheActinic Keratosis Market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2016 -2022.

The base year of this report is 2015.

Tolmar Pharmaceuticals, Inc., DUSA Pharmaceuticals, Inc. (Sun Pharma), Valeant Pharmaceuticals International, Inc., Aqua Pharmaceuticals, LLC . are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Jul 2016
Category:  Medical Devices
Report ID:   58011
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support